Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX8L2F
|
||||
| Drug Name |
N-{1-[2-(4-Methoxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-4-propyl-benzamide
|
||||
| Synonyms |
CHEMBL77471
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C25H35N3O3
|
||||
| Canonical SMILES |
CCCc1ccc(cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCCNc2ccc(OC)cc2
|
||||
| InChI |
InChI=1S/C25H35N3O3/c1-5-6-19-7-9-20(10-8-19)24(29)28-23(17-18(2)3)25(30)27-16-15-26-21-11-13-22(31-4)14-12-21/h7-14,18,23,26H,5-6,15-17H2,1-4H3,(H,27,30)(H,28,29)/t23-/m0/s1
|
||||
| InChIKey |
REQKXASGXDPANT-QHCPKHFHSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.